Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer Stem Cells”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03526328
What this trial is testing

DCLK1 as a Marker/Indicator of Stem Cell Response in Barrett's Esophagus/Esophageal Adenocarcinoma

Who this might be right for
Barrett's EsophagusEsophageal Adenocarcinoma
University of Oklahoma 32
Not applicableNot Yet RecruitingNCT07113730
What this trial is testing

The Kinetics Profiling of Immune Reconstitution and Clinical Outcomes

Who this might be right for
Chronic Myelomonocytic Leukemia (CMML)Immune Reconstitution
Peking University People's Hospital 300
Testing effectiveness (Phase 2)Study completedNCT00003007
What this trial is testing

Interferon Alfa Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
University of Tennessee
Large-scale testing (Phase 3)Active Not RecruitingNCT03246529
What this trial is testing

A Phase III, Safety, Tolerability and Efficacy of Combination Treatment of BL-8040 and Granulocyte Colony Stimulating Factor (G-CSF) as Compared to Placebo and G-CSF for the Mobilization of Hematopoietic Stem Cells for Autologous Transplantation in Subjects With Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
BioLineRx, Ltd. 180
Post-approval studies (Phase 4)Study completedNCT02372357
What this trial is testing

A New Dosing Regimen for Posaconazole Prophylaxis in Children Based on Body Surface Area

Who this might be right for
Hematological Malignancy
Universitaire Ziekenhuizen KU Leuven 14
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07524530
What this trial is testing

Stem Cell Transplantation for Participants With Germline RUNX1 Associated Blood Cancers

Who this might be right for
Core Binding Factor Alpha SubunitsHematologic NeoplasmsLeukemia+1 more
National Cancer Institute (NCI) 102
Not applicableAvailableNCT03145545
What this trial is testing

Expanded Access Protocol Using Alpha/Beta T and CD19+ Depleted PBSC

Who this might be right for
LeukemiaBone Marrow Failure SyndromeImmunodeficiencies
Children's Hospital of Philadelphia
Not applicableStudy completedNCT04710212
What this trial is testing

Screening for Colonization With Resistant Enterobacterales in Neutropenic Patients With Hematologic Malignancies

Who this might be right for
Hematologic MalignancyLeukemia, AcuteNeutropenia+1 more
Duke University 168
Testing effectiveness (Phase 2)Study completedNCT01288573
What this trial is testing

A Combined Study in Pediatric Cancer Patients for Dose Ranging and Efficacy/Safety of Plerixafor Plus Standard Regimens for Mobilization Versus Standard Regimens Alone

Who this might be right for
Ewing's Sarcoma/Soft Tissue SarcomaNeuroblastomaBrain Tumors
Genzyme, a Sanofi Company 46
Testing effectiveness (Phase 2)Study completedNCT01575860
What this trial is testing

Maintenance Lenalidomide in Lymphoma

Who this might be right for
Lymphoma
Abramson Cancer Center at Penn Medicine 8
Testing effectiveness (Phase 2)UnknownNCT01374841
What this trial is testing

Hematopoietic Cell Transplantation for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors

Who this might be right for
Hematologic Neoplasms
European Institute of Oncology 20
Testing effectiveness (Phase 2)Ended earlyNCT01636388
What this trial is testing

Allogeneic Stem Cell Transplantation With Adoptive Immunotherapy in Epstein-Barr Virus Positive Recurrent/Refractory Hodgkins Lymphoma

Who this might be right for
Hodgkins Lymphoma
New York Medical College 2
Testing effectiveness (Phase 2)Study completedNCT04943757
What this trial is testing

Post-transplantation Benadamustine and Cyclophosphamide in Patients With Refractory Myeloid Malignancies

Who this might be right for
Myeloid Leukemia, AcuteChronic Myeloid LeukemiaMyelodysplastic Syndromes+1 more
St. Petersburg State Pavlov Medical University 50
Testing effectiveness (Phase 2)UnknownNCT01665001
What this trial is testing

Personalized Therapy of Precursor Lymphoid Neoplasms

Who this might be right for
Precursor Lymphoid Neoplasms
Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice 200
Very early researchStudy completedNCT00402753
What this trial is testing

Ambulatory Physical Exercise Program in Hematopoietic Stem Cell Transplantation Recipients

Who this might be right for
Hematopoietic Stem Cell Transplantation
University of Zurich 128
Testing effectiveness (Phase 2)Study completedNCT00003877
What this trial is testing

Peripheral Stem Cell Transplantation With or Without Stromagen Following Chemotherapy in Treating Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Roswell Park Cancer Institute 30
Testing effectiveness (Phase 2)UnknownNCT03540849
What this trial is testing

BV After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Hodgkin Lymphoma
University Hospital, Caen 58
Testing effectiveness (Phase 2)Ended earlyNCT02592876
What this trial is testing

Treatment Study of Denintuzumab Mafodotin (SGN-CD19A) Plus RICE Versus RICE Alone for Diffuse Large B-Cell Lymphoma

Who this might be right for
Lymphoma, B-cellLymphoma, Large B-Cell, DiffuseLymphoma, Follicular, Grade 3b+1 more
Seagen Inc. 81
Early research (Phase 1)Study completedNCT00361049
What this trial is testing

Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell Transplant

Who this might be right for
Cancer
Case Comprehensive Cancer Center 49
Testing effectiveness (Phase 2)UnknownNCT04776538
What this trial is testing

Safety and Efficacy of Mesenchymal Stem Cell for Radiation-induced Hyposalivation and Xerostomia in Previous Head and Neck Cancer Patients

Who this might be right for
Xerostomia Following Radiotherapy
Rigshospitalet, Denmark 120
Next Page